APA (7th ed.) Citation

Tsintari, V., Walter, B., Fend, F., Overkamp, M., Rothermundt, C., Lopez, C. D., . . . Kampa-Schittenhelm, K. M. (2022). Alternative splicing of Apoptosis Stimulating Protein of TP53-2 (ASPP2) results in an oncogenic isoform promoting migration and therapy resistance in soft tissue sarcoma (STS). BMC Cancer, 22(1), 1. https://doi.org/10.1186/s12885-022-09726-7

Chicago Style (17th ed.) Citation

Tsintari, Vasileia, Bianca Walter, Falko Fend, Mathis Overkamp, Christian Rothermundt, Charles D. Lopez, Marcus M. Schittenhelm, and Kerstin M. Kampa-Schittenhelm. "Alternative Splicing of Apoptosis Stimulating Protein of TP53-2 (ASPP2) Results in an Oncogenic Isoform Promoting Migration and Therapy Resistance in Soft Tissue Sarcoma (STS)." BMC Cancer 22, no. 1 (2022): 1. https://doi.org/10.1186/s12885-022-09726-7.

MLA (9th ed.) Citation

Tsintari, Vasileia, et al. "Alternative Splicing of Apoptosis Stimulating Protein of TP53-2 (ASPP2) Results in an Oncogenic Isoform Promoting Migration and Therapy Resistance in Soft Tissue Sarcoma (STS)." BMC Cancer, vol. 22, no. 1, 2022, p. 1, https://doi.org/10.1186/s12885-022-09726-7.